Close

Industry Reports

Swedish Primary care group Novakliniken being acquired by Capio

Capio has signed an agreement to acquire 100% of Novakliniken with operations in the southeastern parts of Skåne, Sweden. Novakliniken operates eight primary care centers and two branches, and provides some occupational health and dental services. ...

Reckitt Benckiser’s proposal to buy Pfizer makes sense says JP Morgan

Reckitt Benckiser Group PLC is attempting to buy Pfizer Inc’s consumer healthcare business and analysts at JP Morgan think a potential deal makes sense. “We see a potential acquisition as a strategic step toward building a...

Merck signs its acquisition agreement with Viralytics to Increase its Leading Immuno-Oncolgy Pipeline

Merck , known as MSD outside the USA and Canada, and Viralytics Limited announced that the companies have signed a definitive agreement under which it is proposed that Merck, through a subsidiary, will acquire Viralytics, an Australian publicly traded...

Roche acquires a software company named Flatiron health

Swiss pharmaceutical giant Roche Group is buying Flatiron Health, an Alphabet-backed cancer-focused start-up founded by two former Google employees, according to sources familiar with the matter. The company will pay $1.9 billion, adding to its existing...

Nuvo Pharmaceuticals Acquires U.S. Product Rights to Resultz® from Piedmont Pharmaceuticals LLC

Nuvo Pharmaceuticals Inc.™ , a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, announced that its wholly owned subsidiary, Nuvo Pharmaceuticals (Ireland) Limited (Nuvo Ireland) has acquired the U.S. rights to Resultz® (50% isopropyl...

Sharp completes first phase of $23 million investment in its Bethlehem clinical services facility

Sharp - a part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has completed the first phase in the development of its new USD $23m state-of-the-art facility in Bethlehem, PA. ...

STA Pharmaceutical Sees Rapid Growth in MAH Programs in China

STA Pharmaceutical (STA) – a China-based global API and Drug Product CDMO – reports that it has seen a rapid uptake in companies with intent to market their products in China using it as a development and manufacturing partner...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read